Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANTITHROMBIN III HUMAN Cause Hepatic function abnormal? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hepatic function abnormal have been filed in association with ANTITHROMBIN III HUMAN. This represents 7.6% of all adverse event reports for ANTITHROMBIN III HUMAN.

7
Reports of Hepatic function abnormal with ANTITHROMBIN III HUMAN
7.6%
of all ANTITHROMBIN III HUMAN reports
0
Deaths
7
Hospitalizations

How Dangerous Is Hepatic function abnormal From ANTITHROMBIN III HUMAN?

Of the 7 reports, 7 (100.0%) required hospitalization, and 5 (71.4%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTITHROMBIN III HUMAN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ANTITHROMBIN III HUMAN Cause?

Drug ineffective (19) Off label use (17) Contraindicated product administered (11) Prescribed overdose (11) Foetal exposure during pregnancy (9) Hyperglycaemia (7) Premature baby (7) Adenovirus infection (5) Cholestasis (5) Diarrhoea (5)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

ANTITHROMBIN III HUMAN Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal ANTITHROMBIN III HUMAN Demographics